Carbapenem Use Is Driving the Evolution of Imipenemase 1 Variants

Metallo-β-lactamases (MBLs) are a growing clinical threat because they inactivate nearly all β-lactam-containing antibiotics, and there are no clinically available inhibitors. A significant number of variants have already emerged for each MBL subfamily. To understand the evolution of imipenemase (IM...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Antimicrob Agents Chemother
Prif Awduron: Cheng, Zishuo, Bethel, Christopher R., Thomas, Pei W., Shurina, Ben A., Alao, John-Paul, Thomas, Caitlyn A., Yang, Kundi, Marshall, Steven H., Zhang, Huan, Sturgill, Aidan M., Kravats, Andrea N., Page, Richard C., Fast, Walter, Bonomo, Robert A., Crowder, Michael W.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society for Microbiology 2021
Pynciau:
Mechanisms of Resistance
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8097420/
https://ncbi.nlm.nih.gov/pubmed/33468463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01714-20
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg